A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System
NCT: NCT07477054 · NOT_YET_RECRUITING
Brief Summary
A single-arm, prospective, multicenter cohort study to assess the 30-day continued safety and effectiveness of the AeroPace System in patients on mechanical ventilation (MV) at least 96 hours and who have not weaned. This is a study collecting real-world data in a post-market setting.
Frequently Asked Questions
What is A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System?
A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System is a clinical trial registered under NCT07477054. Current status: NOT_YET_RECRUITING.
What is the status of NCT07477054?
The current status of NCT07477054 (A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System) is: NOT_YET_RECRUITING.
When did A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System start?
A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System started on 2026-10-31.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.